CF33-CD19t

N/A

Report date: 2022/10/24 15:20:02

Base Information

Drug NameCF33-CD19t
Drug Alias NameCF33-CD19t
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionB-lymphocyte antigen CD19 inhibitors
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImugene Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A